Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 139 (3) , 423-429
- https://doi.org/10.1016/s0002-8703(00)90085-1
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Economic Assessment of Low-Molecular-Weight Heparin (Enoxaparin) Versus Unfractionated Heparin in Acute Coronary Syndrome PatientsCirculation, 1998
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimationHealth Economics, 1997
- Users' Guides to the Medical LiteratureJAMA, 1997
- Bootstrap Methods: Another Look at the JackknifeThe Annals of Statistics, 1979